Ginkgo Bioworks
Programming cells for biotech, agriculture, and industry.
About Ginkgo Bioworks
Cell engineering platform building organisms for everything from fragrances to vaccines. SPAC'd 2021.
Pitch deck breakdown
How Ginkgo Bioworks would pitch themselves.
Target customer
Biotech — the core audience Ginkgo Bioworks's product is built around.
Problem they solve
Cell engineering platform building organisms for everything from fragrances to vaccines. SPAC'd 2021. The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Ginkgo Bioworks differentiates on programming cells for biotech, agriculture, and industry. Backed by Cascade + Viking Global — the company has resources + validation to compound this thesis. Founded by Jason Kelly + team.
Go-to-market strategy
Late-stage scale — global enterprise sales force, channel + reseller partnerships, vertical-specific go-to-market motions. Focus on land-and-expand within existing accounts + international expansion.
Company facts
- Category
- Other
- Funding stage
- IPO 2021
- Total raised
- Public (NYSE: DNA)
- Founded
- 2008
- Team size
- 1001+
- HQ
- Boston
- Country
- United States
- Website
- ginkgobioworks.com
Founders of Ginkgo Bioworks
- Jason Kelly
- Reshma Shetty
- Tom Knight
- Austin Che
- Barry Canton
Investors backing Ginkgo Bioworks
- Cascade
- Viking Global
Frequently asked questions
What does Ginkgo Bioworks do?
Cell engineering platform building organisms for everything from fragrances to vaccines. SPAC'd 2021.
Where is Ginkgo Bioworks based?
Ginkgo Bioworks is based in Boston, United States.
When was Ginkgo Bioworks founded?
Ginkgo Bioworks was founded in 2008.
How much has Ginkgo Bioworks raised?
Ginkgo Bioworks has raised Public (NYSE: DNA) in their IPO 2021 round.
Who founded Ginkgo Bioworks?
Ginkgo Bioworks was founded by Jason Kelly, Reshma Shetty, Tom Knight, Austin Che, Barry Canton.
Who has invested in Ginkgo Bioworks?
Ginkgo Bioworks is backed by Cascade, Viking Global.